Candriam S.C.A. Kezar Life Sciences, Inc. Transaction History

Candriam S.C.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 20, 2021	SELL	$4.93 - $6.46 $2.88 Million - $3.78 Million	-584,956 Closed	0 $0
Q4 2020 Jan 22, 2021	SELL	$4.77 - $6.58 $71,759 - $98,989	-15,044 Reduced 2.51%	584,956 $3.05 Million
Q2 2020 Jul 23, 2020	BUY	$3.6 - $7.75 $2.16 Million - $4.65 Million	600,000 New	600,000 $3.11 Million

39.1M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $514M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.